Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Change in Acquisitions & Divestments: 2013-2024

Historic Change in Acquisitions & Divestments for Capricor Therapeutics (CAPR) over the last 11 years, with Dec 2024 value amounting to $93.8 million.

  • Capricor Therapeutics' Change in Acquisitions & Divestments rose 257.66% to $78.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.1 million, marking a year-over-year increase of 121.36%. This contributed to the annual value of $93.8 million for FY2024, which is 10.33% down from last year.
  • As of FY2024, Capricor Therapeutics' Change in Acquisitions & Divestments stood at $93.8 million, which was down 10.33% from $104.6 million recorded in FY2023.
  • In the past 5 years, Capricor Therapeutics' Change in Acquisitions & Divestments registered a high of $104.6 million during FY2023, and its lowest value of $12.1 million during FY2020.
  • For the 3-year period, Capricor Therapeutics' Change in Acquisitions & Divestments averaged around $93.6 million, with its median value being $93.8 million (2024).
  • In the last 5 years, Capricor Therapeutics' Change in Acquisitions & Divestments soared by 303.90% in 2020 and then decreased by 10.33% in 2024.
  • Capricor Therapeutics' Change in Acquisitions & Divestments (Yearly) stood at $12.1 million in 2020, then reached $82.5 million in 2022, then grew by 26.78% to $104.6 million in 2023, then dropped by 10.33% to $93.8 million in 2024.